M 617 (Levetiracetam 750 mg)
Pill with imprint M 617 is White, Capsule-shape and has been identified as Levetiracetam 750 mg. It is supplied by Mylan Pharmaceuticals Inc.
Levetiracetam is used in the treatment of seizures; epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 617
Levetiracetam
- Imprint
- M 617
- Strength
- 750 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
sodium lauryl sulfate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-5617 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0822 (Discontinued) | UDL Laboratories Inc. |
Related Images for "M 617"
More about levetiracetam
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (376)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: pyrrolidine anticonvulsants
- Latest FDA Alerts (4)
Patient resources
- Drug Information
- Levetiracetam (Advanced Reading)
- Levetiracetam Intravenous (Advanced Reading)
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
- Other brands
- Keppra, Keppra XR, Spritam, Roweepra, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.